Syngene to acquire Stelis Biopharma’s biologics manufacturing facility in Bangalore
Pharma manufacturing services company Syngene International has unveiled plans to acquire Unit 3 biologics manufacturing facility located in Bangalore, India from Stelis Biopharma Limited (SBL). ... Read More
Syngene signs Librela-focused biologics manufacturing agreement with Zoetis
Syngene International Limited has signed a 10-year biologics manufacturing agreement with American animal health company Zoetis for manufacturing the drug substance for Librela (bedinvetmab), a ... Read More